Bioscience Symposium Schedule

Thursday, January 19, 2017, Cole Assembly Room, Converse Hall

3 p.m. Introductory remarks by George Carmany ’62. Carmany is an investor in health care in Boston, the former chairman of the Tufts Medical Center and a member of the Advisory Committee on Education at the Harvard Medical School. Carmany and Gerald Fink ’62 are the co-founders of the Fink Symposium.

3:05 p.m. Brief observations on Rice Leach ’62 by his classmate, Marc Pohl ’62

3:15 p.m. Talk by David M. Lawrence ’62, "Remembering Rice Leach, Public Health Leader", a relentless advocate for the disenfranchised; a lifetime student of disparities in health status and health access; and a tireless explorer of how to address the social determinants of health. Dr. Lawrence will also address "Accessibility to Care."

3:55 p.m. "A Personal Perspective on Global Health", talk by Barry Bloom ’58

4:35 p.m. Discussion between David M. Lawrence ’62 and Barry Bloom ’58

4:55 p.m. "New Modalities of Cancer Treatment", Gerald R. Fink ’62

5:10 p.m. "The Next Generation of Cancer Immunotherapy", talk by Kipp Weiskopf ’07

5:40 p.m. "Understanding CRISPR: An Undergrad’s Story", talk by Isaiah Holloway ’17

6:10 p.m. Discussion on career progression from Amherst to M.D., Ph.D. and beyond, with Kipp Weiskopf ’07 and Isaiah Holloway ’17, moderated by Doug Lowy ’64

6:30 p.m. All depart for the Lewis Sebring Dining Commons.

6:45 p.m. Reception and Dinner - Lewis-Sebring Commons at Valentine Hall.

7:45 p.m. Keynote speaker Dr. Douglas Lowy ’64, the acting director of the National Cancer Institute, will discuss a topic of increasing importance to cancer, “Precision medicine: from prevention to therapy.” This approach, which depends on a molecular understanding of disease, is often considered to be mainly relevant to the treatment of disease. However, it can also be important for preventing disease.

8:15 p.m. Q & A Session

9 p.m. Event Concludes